Private Equity

Healthcare

Behrman Capital invests in Emmes

Behrman Capital has made an investment in Maryland-based Emmes, a healthcare contract research organization. No financial terms were disclosed.

3 min read · 05 March 2019

Catalyst Clinical buys certain Triangle Biostatistics assets

Catalyst Clinical Research LLC, a portfolio company of NovaQuest Capital Management LLC, said March 5 that it acquired certain assets of Triangle Biostatistics LLC. Financial terms weren’t announced. Triangle, with offices in Raleigh and Wilmington, North Carolina, provides statistical programming, statistical consulting, and data management services for the pharmaceutical, biotechnology and medical device industries.

3 min read · 05 March 2019

Housatonic's Aegis, California opioid-treatment group, seeks buyer

2 min read · 04 March 2019

Riverside acquires ADA as an add-on

The Riverside Company has acquired ADA Solutions, a provider of solutions for the visually impaired. No financial terms were disclosed. The transaction was an add-on acquisition for Riverside portfolio company SureWerx. Golub Capital provided debt financing for the deal.

2 min read · 04 March 2019

New Heritage Capital invests in Rhythmlink

New Heritage Capital has made an investment in Columbia, South Carolina-based Rhythmlink International LLC, a maker of disposable neurodiagnostic devices and consumables. No financial terms were disclosed.

2 min read · 04 March 2019

Wellspring buys PE-backed Center for Diagnostic Imaging

2 min read · 04 March 2019

Five Questions with Kristin Mugford, Harvard lecturer, mentor to women in PE

4 min read · 04 March 2019

Water Street invests in Pathnostics

Water Street Healthcare Partners has made an investment in Irvine, California-based Pathnostics, a provider of diagnostic solutions. No financial terms were disclosed.

3 min read · 27 February 2019

TPG-backed WellSky acquires HCS

WellSky, which is backed by TPG Capital, has acquired New Jersey-based Health Care Software Inc, a provider of integrated clinical and financial IT software for long-term and post-acute care providers. No financial terms were disclosed.

4 min read · 27 February 2019

Blackstone Life Sciences invests $250 mln in Anthos Therapeutics

Blackstone Life Sciences said Feb. 27 that it launched Anthos Therapeutics Inc, a biopharmaceutical company focused on advancing targeted therapies for high-risk cardiovascular patients. Blackstone is investing $250 million in Anthos. Novartis will have a minority.

4 min read · 27 February 2019

Showing 4,671 to 4,680 of 5,654 results
1…467469…566